JP2013528589A5 - - Google Patents

Download PDF

Info

Publication number
JP2013528589A5
JP2013528589A5 JP2013509213A JP2013509213A JP2013528589A5 JP 2013528589 A5 JP2013528589 A5 JP 2013528589A5 JP 2013509213 A JP2013509213 A JP 2013509213A JP 2013509213 A JP2013509213 A JP 2013509213A JP 2013528589 A5 JP2013528589 A5 JP 2013528589A5
Authority
JP
Japan
Prior art keywords
ophthalmic composition
composition according
hyperbranched polymer
active ingredient
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013509213A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013528589A (ja
Filing date
Publication date
Priority claimed from US12/774,419 external-priority patent/US8211450B2/en
Application filed filed Critical
Publication of JP2013528589A publication Critical patent/JP2013528589A/ja
Publication of JP2013528589A5 publication Critical patent/JP2013528589A5/ja
Pending legal-status Critical Current

Links

JP2013509213A 2010-05-05 2011-05-04 眼科用組成物 Pending JP2013528589A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12/774,419 US8211450B2 (en) 2010-05-05 2010-05-05 Ophthalmic composition
US12/774,419 2010-05-05
PCT/US2011/035147 WO2011140194A1 (en) 2010-05-05 2011-05-04 Ophthalmic composition

Publications (2)

Publication Number Publication Date
JP2013528589A JP2013528589A (ja) 2013-07-11
JP2013528589A5 true JP2013528589A5 (OSRAM) 2015-02-19

Family

ID=44902332

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013509213A Pending JP2013528589A (ja) 2010-05-05 2011-05-04 眼科用組成物

Country Status (8)

Country Link
US (2) US8211450B2 (OSRAM)
EP (1) EP2566487A4 (OSRAM)
JP (1) JP2013528589A (OSRAM)
KR (1) KR20130121685A (OSRAM)
CN (1) CN103096901A (OSRAM)
CA (1) CA2797123A1 (OSRAM)
MX (1) MX2012012846A (OSRAM)
WO (1) WO2011140194A1 (OSRAM)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012014986A1 (ja) * 2010-07-29 2012-02-02 参天製薬株式会社 薬剤付き支持体及びその製造方法
WO2013114397A2 (en) * 2012-01-16 2013-08-08 Biocon Limited Pharmaceutically acceptable salt of brinzolamide and composition thereof
US9820991B2 (en) * 2013-11-08 2017-11-21 Sentiss Pharma Private Limited Pharmaceutical composition comprising brinzolamide
CN103740831B (zh) * 2014-01-13 2015-01-28 宁波海尔施基因科技有限公司 一种指导β-受体阻断药用药的引物组合物、多重基因检测试剂盒及其使用方法
PT3096740T (pt) * 2014-01-24 2020-12-24 Sentiss Pharma Private Ltd Composição farmacêutica que compreende brinzolamida
PT3142993T (pt) 2014-05-16 2018-12-18 Occidental Chem Co Método para preparar 1,1,3,3-tetracloropropeno
JP6373995B2 (ja) * 2014-07-11 2018-08-15 富士フイルム株式会社 眼科用水性組成物
WO2016022066A1 (en) 2014-08-04 2016-02-11 Jerry Tan Eye Surgery Pte Ltd Pharmaceutical compositions for demodex related blepharitis and eyelid crusting
KR101773669B1 (ko) 2015-07-30 2017-08-31 포항공과대학교 산학협력단 생체적합성 각막세포 전구체 분화방법 및 각막세포 전구체 조성물
JP6050454B1 (ja) * 2015-09-28 2016-12-21 参天製薬株式会社 水性医薬組成物
TW201733577A (zh) * 2016-03-14 2017-10-01 Santen Pharmaceutical Co Ltd 含有多佐胺、噻嗎洛爾和界面活性劑之醫藥組成物
KR20250065422A (ko) 2017-12-15 2025-05-12 타르서스 파마수티칼스, 아이엔씨. 안검염을 치료하기 위한 이속사졸린 구충제 제제 및 방법
US20220265695A1 (en) 2019-07-26 2022-08-25 Proqr Therapeutics Ii B.V. Opthalmic compositions comprising viscosifying polymers and nucleic acids
JP7479744B2 (ja) * 2022-01-21 2024-05-09 センジュ ユーエスエー、インコーポレイテッド 水性液剤
CN118978426B (zh) * 2024-10-22 2025-05-16 浙江大学 一种甘油的酸化处理方法、酸化甘油及其应用

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5136014A (en) * 1990-06-22 1992-08-04 E. I. Du Pont De Nemours And Company Hyperbranched polyesters
WO1992018124A1 (en) * 1991-04-17 1992-10-29 Merck & Co., Inc. OPHTHALMIC COMPOSITIONS COMPRISING COMBINATIONS OF A CARBONIC ANHYDRASE INHIBITOR AND A β-ADRENERGIC ANTAGONIST
US6316443B1 (en) * 1994-08-04 2001-11-13 Merck & Co., Inc. Ophthalmic compositions comprising combinations of a carbonic anhydrase inhibitor and a β-adrenergic antagonist
DE19726186A1 (de) * 1997-06-20 1998-12-24 Boehringer Ingelheim Int Komplexe für den Transport von Nukleinsäure in höhere eukaryotische Zellen
FR2772771B1 (fr) * 1997-12-19 2000-01-28 Oreal Utilisation de polymeres hyperbranches et de dendrimeres comportant un groupement particulier, en tant qu'agent filmogene, les compositions filmogenes les comprenant et leur utilisation notamment en cosmetique ou en pharmacie
WO2000063409A1 (en) 1999-04-21 2000-10-26 Massachusetts Institute Of Technology Endosomolytic agents and cell delivery systems
US7030097B1 (en) 1999-07-14 2006-04-18 Cornell Research Foundation, Inc. Controlled nucleic acid delivery systems
SK282717B6 (sk) 2000-03-10 2002-11-06 �Stav Experiment�Lnej Farmakol�Gie Sav Spôsob prípravy ultravysokomolekulových hyalurónanov
WO2002026867A2 (en) 2000-09-29 2002-04-04 The Regents Of The University Of California Dendrimeric support or carrier macromolecule
JP2004523624A (ja) 2001-02-26 2004-08-05 デューク ユニバーシティ 新規なデンドリティックポリマー、およびその生物医学的使用
ES2295347T3 (es) 2001-03-08 2008-04-16 Nymox Pharmaceutical Corporation Uso de proteinas de la cadena neural para tratar tumores.
FR2830450B1 (fr) 2001-10-09 2004-02-06 Univ Pasteur Utilisation de dendrimeres dans une composition ophtalmique
AR038269A1 (es) 2002-01-09 2005-01-12 Novartis Ag Articulos polimericos que tienen un recubrimiento lubrico, y metodo para fabricarlos
GB0209022D0 (en) 2002-04-19 2002-05-29 Imp College Innovations Ltd Compounds
WO2004060283A2 (en) 2002-12-16 2004-07-22 Nitromed, Inc. Nitrosated and nitrosylated rapamycin compounds, compositions and methods of use
NZ574134A (en) * 2003-02-13 2011-03-31 Dimitrios Tsiourvas Multifunctional dendrimers and hyperbranched polymers as drug and gene delivery systems
JP2005008614A (ja) 2003-03-28 2005-01-13 Nano Career Kk 高分子ミセルを用いた眼科用ドラッグデリバリーシステム
US7109247B2 (en) 2003-05-30 2006-09-19 3M Innovative Properties Company Stabilized particle dispersions containing nanoparticles
US7189456B2 (en) 2004-03-04 2007-03-13 Transitions Optical, Inc. Photochromic optical article
WO2006031358A2 (en) 2004-08-13 2006-03-23 Hyperbranch Medical Technology, Inc. Dendritic polymers, crosslinked gels, and their uses as ophthalmic sealants and lenses
US20060057215A1 (en) * 2004-09-15 2006-03-16 Raiche Adrian T Method for the production of nanoparticles and microparticles by ternary agent concentration and temperature alteration induced immiscibility
US7837986B2 (en) 2004-12-01 2010-11-23 E. I. Du Pont De Nemours And Company Protein-based polymer tissue adhesives for medical use
EP1879551A2 (de) * 2005-02-21 2008-01-23 Basf Aktiengesellschaft Wirkstoffzusammensetzung die wenigstens ein stickstoffatomhaltiges, hyperverzweigtes polymer enthält
US20060257359A1 (en) 2005-02-28 2006-11-16 Cedric Francois Modifying macrophage phenotype for treatment of disease
US8679536B2 (en) 2005-08-24 2014-03-25 Actamax Surgical Materials, Llc Aldol-crosslinked polymeric hydrogel adhesives
US7666331B2 (en) 2005-08-31 2010-02-23 Transitions Optical, Inc. Photochromic article
CN104524596B (zh) 2006-01-20 2018-10-09 星药股份有限公司 经修饰的大分子
EP1991277A4 (en) 2006-03-03 2010-12-22 Dendritic Nanotechnologies Inc DELIVERY OF BIOLOGICALLY ACTIVE MATERIALS WITH CORE-SHELL TECTO (DENDRITEN POLYMERS)
US20080031916A1 (en) * 2006-04-24 2008-02-07 Heather Sheardown Dendrimer cross-linked collagen
WO2008027340A2 (en) * 2006-08-30 2008-03-06 Merck & Co., Inc. Topical ophthalmic formulations
WO2008030591A2 (en) 2006-09-08 2008-03-13 Dendritic Nanotechnologies, Inc. Peham dendrimers as excipients
WO2008067127A2 (en) * 2006-11-09 2008-06-05 Alcon Research, Ltd. Water insoluble polymer matrix for drug delivery
US7906214B2 (en) 2007-01-26 2011-03-15 Transitions Optical, Inc. Optical elements comprising compatiblizing coatings and methods of making the same
PL2214646T3 (pl) * 2007-10-05 2021-12-20 Wayne State University Dendrymery do przedłużonego uwalniania związków
EP2214731B1 (en) 2007-11-14 2014-05-14 Actamax Surgical Materials LLC Oxidized cationic polysaccharide-based polymer tissue adhesive for medical use
US20100008993A1 (en) 2008-07-14 2010-01-14 Proksch Joel W Compositions and Methods for Increasing Bioavailability of Topical Ophthalmic Drugs
WO2010017184A2 (en) * 2008-08-08 2010-02-11 Virginia Commonwealth University Dendrimer hydrogels

Similar Documents

Publication Publication Date Title
JP2013528589A5 (OSRAM)
CA2797123A1 (en) Ophthalmic composition
TWI323274B (en) Polishing composition and method for high silicon nitride to silicon oxide removal rate ratios
TWI313703B (en) Cmp composition comprising surfactant
JP2011530166A5 (OSRAM)
CN102257092B (zh) 含有非离子型聚合物的浆料组合物及使用方法
TW201525121A (zh) 用於選擇性移除氮化矽之化學機械拋光(cmp)組合物及方法
WO2012142374A3 (en) Compositions and methods for selective polishing of silicon nitride materials
JP2013537874A5 (OSRAM)
TW201900795A (zh) 研磨用組成物及矽晶圓之研磨方法
EP2576721A4 (en) TENSIDLESS ALKALI POLYMER FORMULATIONS FOR THE RECONSTRUCTION OF REACTIVE CRUDE OIL
WO2010111576A3 (en) Aminated polymers and their use in water-borne compositions
JP2015529283A (ja) 液体洗濯洗剤組成物用の外部構造化系
WO2012102799A3 (en) Method, composition and package for bowel cleansing
WO2012004082A3 (de) Quartäre-aminoalkoholfunktionelle, siliciumorganische verbindungen, diese enthaltende zusammensetzung sowie deren herstellung und verwendung
RU2012117238A (ru) Густые кислотные абразивные чистящие составы
JP2012172117A5 (OSRAM)
WO2012103091A3 (en) Abrasive free silicon chemical mechanical planarization
AR080076A1 (es) Producto de cuidado oral para el cuidado de esmalte sensible
JP2016522857A5 (OSRAM)
JP2015521147A5 (OSRAM)
CN103391993B (zh) 包含巯基吡啶氧化物源的条皂
CN112689498B (zh) 个人清洁组合物
WO2013068707A8 (en) Compositions and methods relating to the stabilization of hydrophobically modified hydrophilic polymer treatment fluids under alkaline conditions
MX359814B (es) Composicion polimerica dispersable acuosa.